Sun Pharma arm settles case with Biofrontera, to get $22.5 million
Sun pharma's US subsidiary DUSA pharmaceuticals on Wednesday said that the company has filed a law suit against German drug maker Biofrontera for patent infringement, trade secret misappropriation and tortious interference claims in an on going patent infringement suit.
Levulan (Aminolevulinic Acid): DUSA Pharmaceuticals v. Biofrontera